HAEMONETICS CP (HAE)
 
Quote Price $69.26
Price change for today in $ 0.00
Price change for today in % 0.00
Open Price $0.00
Previous Close $69.26
Daily Range $0.00 - $0.00
52-Week Range $54.99 - $73.49
Volume 0
 
 
Brokerage Analyst Recommendations 
7 Brokerage Firms Covering HAE
 
  
Strong Buy
3 		Buy
0 		Hold
4		 Sell
0		 Strong Sell
0
Average Broker Recommendation (ABR):2.14 
 
Description
Haemonetics is a global company engaged in the design, manufacture and worldwide marketing of automated blood processing systems. These systems address important medical markets: surgical blood salvage, blood component collections and plasma collections. The majority of their business is outside the US.
 
400 WOOD RD
BRAINTREE, MA
02184, USA
Phone: 7818487100
Fax: 781-848-5106
Web: http://www.haemonetics.com
Email: nfo@rtco.com		 Industry:MED PRODUCTS
Sector: Medical
Fiscal Year End:March
Last Reported Quarter:03/31/12
Next EPS Date:08/06/12
 
Capital Structure Solvency and Cash Flow
No comments yet. Be the first
make a comment about Capital Structure Solvency and Cash Flow
 
Governance Social Responsibility and Employee Relations
No comments yet. Be the first
make a comment about Governance Social Responsibility and Employee Relations
 
Acquisitions Divestitures and Joint Ventures
No comments yet. Be the first
make a comment about Acquisitions Divestitures and Joint Ventures
 
Recent and Upcoming Events
May 22, 2012 08:00 Haemonetics to Present at the Jefferies 2012 Global Healthcare Conference
May 22, 2012 07:53 Haemonetics releases new blood management intelligence portal
May 08, 2012 10:03 Haemonetics In Retrospect: Shares Down 0.2% Since Upgraded One Week Ago (HAE)
May 08, 2012 08:00 Haemonetics Releases Next Generation of IMPACTA? Online Blood Utilization Portal
May 03, 2012 16:30 Haemonetics to Present at Bank of America Merrill Lynch 2012 Health Care Conference
May 02, 2012 08:03 Upgrade Alert for Haemonetics (HAE)
May 01, 2012 21:14 Haemonetics Corporation (HAE) Corporate Event Announcement Notice
May 01, 2012 15:13 Haemonetics Looks to Continue to Trade Above its Annual-High Share Price Today
Apr 30, 2012 20:53 Haemonetics Corporation (HAE) Corporate Event Announcement Notice
Apr 30, 2012 14:44 Haemonetics to acquire Hemerus Medical
Apr 30, 2012 11:05 Buyers Accumulate Shares of Haemonetics, Up 4.0%
Apr 30, 2012 06:57 Haemonetics Sees Earnings Below Estimates
Apr 29, 2012 12:49 Pall Announces 10:00 a.m. EDT Webcast on Monday, April 30 to Discuss Agreement to Sell Blood Product Lines
Apr 29, 2012 12:05 Haemonetics Changes Timing of Fourth Quarter and Year End Fiscal Year 2012 Webcast: April 30, 2012 at 8:00 am Eastern Time
Apr 29, 2012 12:04 Haemonetics Reports 10% Revenue Growth for Fourth Quarter of Fiscal 2012 and $0.80 Adjusted EPS; Also Establishes Fiscal 2013 Guidance

 
Major Risks
No comments yet. Be the first
make a comment about Major Risks
 


Created by: WikiMigrationBot. Last Modification: Thursday 03 of June, 2010 07:18:20 CDT by WikiMigrationBot.